FEATURED ARTICLES
-
Scientific Data Is Not AI‑Ready By Default
Convert siloed laboratory data into trusted, AI-ready assets. Learn to enforce data integrity principles at the point of origin to streamline analytics and reduce GxP compliance risks.
WHITE PAPERS & CASE STUDIES
-
Context-First Data For Trustworthy AI In Biopharma
Bridge the gap between AI experimentation and enterprise value. Learn how capturing structured, semantically rich data at the point of origin builds regulator-credible AI pipelines.
-
Top Questions Before You Buy A Hazardous Pharmacy Compounding Isolator
Move beyond brochure specifications for hazardous compounding. Learn the critical airflow, structural, and pressure requirements needed to ensure long-term facility safety.
-
Where Speed Meets Complexity In Bioprocess Development
Bioprocessing faces mounting pressure to compress timelines, especially for mAbs, while complex modalities like bispecifics and gene therapies introduce technical challenges. Process intensification, scale-up translation, and comparability risks remain critical hurdles.
-
Unlocking The Full Potential Of Antibody-Drug Conjugates (ADCs)
ADCs are evolving rapidly. Gain insight into how success now hinges on managing complexity, delivery, and scalability to turn promising designs into viable therapeutic products.
-
ADC Manufacturing: Practices, Challenges, And The Road Ahead
ADCs are advancing quickly, but manufacturing complexity is rising just as fast. Key challenges in scale-up, regulation, and costs are reshaping how the next generation of therapies will be delivered.
-
Leveraging Integrated Media Services For Speed And Efficiency
Uncertainty in media stability can limit efficiency and scalability in biologics manufacturing. See how a data-driven approach enables more predictable planning and reduces operational strain.